| Zacks Company Profile for Grifols, S.A. (GRFS : NSDQ) |
|
|
| |
| • Company Description |
| Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Number of Employees: 23,822 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $9.75 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 743,955 shares |
| Shares Outstanding: 687.55 (millions) |
| Market Capitalization: $6,703.66 (millions) |
| Beta: 0.55 |
| 52 Week High: $9.95 |
| 52 Week Low: $6.19 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
8.57% |
4.51% |
| 12 Week |
37.71% |
15.83% |
| Year To Date |
31.05% |
22.73% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
152-158 PARC DE NEGOCIS CAN SANT JOAN SANT CUGAT DEL VALL?S
-
BARCELONA,U3 08174
ESP |
ph: 34-93-571-2200
fax: 34-93-800-8000 |
investors@grifols.com |
http://www.grifols.com |
|
|
| |
| • General Corporate Information |
Officers
Jose Ignacio - Chief Executive Officer
Thomas H. Glanzmann - Non-Executive Chairperson
Raimon Grifols Roura - Vice-Chairperson
Victor Grifols Deu - Chief Operating Officer
Rahul Srinivasan - Chief Financial Officer
|
|
Peer Information
Grifols, S.A. (GSAC)
Grifols, S.A. (CASI)
Grifols, S.A. (ALCD.)
Grifols, S.A. (OMNN)
Grifols, S.A. (CGPI.)
Grifols, S.A. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 398438408
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/24
Next Expected EPS Date: 07/29/25
|
|
Share - Related Items
Shares Outstanding: 687.55
Most Recent Split Date: 1.00 (2.00:1)
Beta: 0.55
Market Capitalization: $6,703.66 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $0.96 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: 28.88% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/29/25 |
|
|
|
| |
